Skip to main content Skip to Footer

LATEST THINKING


State of content for Life Sciences

Pharma, biotech and medical technology marketing leaders share how they are managing the rising amount of digital content

Overview

Digital content is massively growing…but digital content strategies and objectives are not clear to most life sciences marketers.

Accenture Interactive surveyed 55 pharmaceutical and biotech and 53 medical technology marketing leaders to better understand their attitudes, insights and strategies for managing digital content now and in the future.*

image

55

PHARMACEUTICAL & BIOTECH

image

53

MEDICAL TECHNOLOGY

image

ALL

INDUSTRIES

Our research showed that companies are struggling to manage the amount of content they have today…and it's massively growing. Most life sciences marketers lack clarity on their company's content strategy and objectives. But it also unveiled some crucial ways to solve the issue – from rethinking content strategy to streamlining day-to-day operations.

DOWNLOAD THE INFOGRAPHIC [PDF]

Content Overload

Life sciences companies are producing a massive amount of digital content—and it is growing.

image

78% of marketers in pharma and biotech and 95% of marketers in medical technology say their organization is producing a moderate to enormous amount of digital content and assets.

image

93% of pharma and biotech respondents and 100% of the respondents from med tech say the volume of digital content and assets is higher today than it was two years ago.

High Spend

58% of pharma/biotech and 60% of med tech companies spend more than $50 million on content each year.

Investment Risks

image
image

Lack of a content strategy and objectives puts growing investment and dollars at risk

Content strategy and objectives are not clear to most marketers in life sciences.

Only 4% in med tech and 11% in pharma/biotech report they have a clearly documented content strategy that meets their current and future needs (compared to 42% across all industries)

image

Only 6% of med tech marketers and 9% of pharma/biotech marketers feel objectives are clearly laid out (versus 19% across all industries)

image


Content Success

image
image

Pharma, biotech and med tech marketers are using a multitude of activities to tackle the growing volume of content. However, without a clear strategy and objectives, these activities independently will struggle to overcome operational challenges and improve the way companies engage with their customers.

Taking Action

To successfully manage content in this complex environment, pharma, biotech and med tech companies will need to:

About the Research

The Inaugural State of Content Survey by Accenture Interactive reports the attitudes, insights and strategies for managing digital content now and in the future. The online survey targeted 1078 senior executives across 14 industries and spanning 17 countries who have decision-making responsibilities for the creation, development and management of content within their organizations, both internally and externally. This report summarizes the key findings from the Life Sciences (pharmaceutical and medical technology) respondents. 

Life Sciences company respondents were from the following countries: 

Flags


For more information, please contact:

SUGGESTED CONTENT